BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent

Clinical trial NCT02068846 · COMPLETED

Trial details

NCT number: NCT02068846
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Salivary Gland Disease Benign Lymphoepithelial Lesion

Start date: 2014-04-01
Primary completion: 2016-01-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.